Electronic cigarettes are at least as effective as nicotine patches for smoking cessation

Evidence-Based Medicine

Volumn 19, Issue 4, 2014, Pages 133-

  Shahab, Lion ^a   Goniewicz, Maciej ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINE GUM; NICOTINIC AGENT;

FEMALE; HUMAN; MALE; PREVENTION AND CONTROL; PROCEDURES; SMOKING; SMOKING CESSATION; STANDARDS; TOBACCO USE DISORDER;

FEMALE; HUMANS; MALE; NICOTINE; NICOTINIC AGONISTS; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 84905861130     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/eb-2013-101690     Document Type: Note

References (6)

1. Goniewicz ML, Kuma T, Gawron M, et al. Nicotine levels in electronic cigarettes. Nicotine Tob Res 2013;15:158-66.
2. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014;23:133-9.
3. Shahab L, Brose LS, West R. Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems. CNS Drugs 2013;27:1007-19.
4. Cobb N, Cobb C. Regulatory challenges for refined nicotine products. Lancet Respir Med 2013;1:431-3.
5. Benowitz NL, Goniewicz ML. The regulatory challenge of electronic cigarettes. JAMA 2013;310:685-6.
6. Hajek P. Electronic cigarettes for smoking cessation. Lancet 2013;382:1614-16.